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Abstract
Introduction. An altered gut microbiome composition is shown to be associated
with various diseases and health outcomes. We compare the gut microbiota of
women who developed gestational diabetes mellitus (GDM) with that of those who
did not, and the gut microbiota of their offspring, to determine any differences in
the composition and diversity of their gut microbiota, which may be correlated with
their GDM state. Material and methods. All women were at high risk for GDM
and participated in the Finnish Gestational Diabetes Prevention Study
(RADIEL). Stool samples were obtained, 5 years postpartum, from 60 GDM-
positive women, 68 non-GDM control women, and their children (n = 109), 237
individuals in total. 16S ribosomal RNA gene sequencing was employed to
determine the composition of bacterial communities present. Statistical
correlations were inferred between clinical variables and microbiota, while taking
into account potential confounders. Results. In mothers, no significant
differences were observed in microbiota composition between the two groups.
Genus Anaerotruncus was increased in children of women with GDM
(p < 0.001). Beta-diversity measures showed that a mother and her child have a
more similar microbiome composition when compared with unrelated children,
other mothers, or the children compared with each other (p < 0.001).
Conclusions. These results suggest that there may be no discernible microbiome
basis to GDM susceptibility in high-risk women, whereas microbiome differences
between the offspring could be of greater biological significance. The
heterogeneous nature of the disease could be obscuring potential differences
between women. A longer time-series study, with carefully defined subject
subgroups, may be an appropriate course of future investigation into GDM and
the microbiome.
Abbreviations: 16S, 16S ribosomal RNA gene; GDM, gestational diabetes
mellitus; OTU, Operational Taxonomic Unit; PCR, polymerase chain reaction.
Introduction
The incidence of gestational diabetes mellitus (GDM) is
on the rise globally (1). GDM can have a long-lasting
effect on both the women and their offspring, including
an increased risk of developing obesity, metabolic
Key Message
Here we look at the relation between gestational dia-
betes and the gut microbiome in both mothers and
children and suggest potential future avenues of study
for this new direction in exploring diabetes mellitus.
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syndrome and type 2 diabetes, which may be transmitted
via the microbiome (2–5).
Because of its large impact on human health and dis-
ease, the microbiome has come under increasing scrutiny
over the last decade. The gastrointestinal tract is the best
characterized microbiome within the human body and
our knowledge of it is constantly expanding. The preva-
lence of obesity is increasing worldwide, and obesity is a
key risk factor for a number of noncommunicable dis-
eases including type 2 diabetes, coronary heart disease
and several cancers (6–8). Multiple studies have shown a
link between the gut microbiome and obesity, in particu-
lar the ratio of the abundances of the phyla Bacteroidetes
and Firmicutes (9,10).
Studies investigating the relation between diabetes and
the gut microbiome have shown a decreased microbial
diversity in people with type 1 diabetes compared with
controls, as well as a marked difference in the ratio of
Bacteroidetes and Firmicutes abundance between the two
groups (11,12). A number of functional differences in the
gut microbiota have been observed between people with
type 2 diabetes and control subjects, from deficiency in
butyrate biosynthesis and glucose metabolism to higher
levels of pathogens such as Escherichia coli, although some
of the differences associated with type 2 diabetes may be
driven by medications such as metformin (13–15).
The gut microbiome’s influence and importance in the
pathogenesis of GDM is yet to be explicitly studied. It
has been shown that the microbiome may be severely
remodeled during pregnancy with reduced diversity and
bacterial richness observed in the third trimester, com-
pared with the first trimester (16). However, this was not
confirmed in a more recent study with serial collection of
stool throughout pregnancy (17).
Current research linking the gut microbiome to GDM has
so far produced very few insights, and the role of the gut
microbiome in GDM has yet to be elucidated. Moreover, no
study has looked at the long-term effects of GDM on the
microbiota of children from GDM pregnancies and whether
this might contribute to their increased risk of developing
diabetes and other metabolic disorders in the future.
Here we aim to compare the gut microbiota, 5 years
postpartum, of women who had been diagnosed with
GDM, to that of high-risk women with normal glycemic
control originating from the Finnish Gestational Diabetes
Prevention Study (RADIEL) (18).
Material and methods
Study subjects and sample collection
This study was based on samples obtained 5 years after
delivery from participants in the RADIEL study, a
randomized controlled intervention trial between Febru-
ary 2008 and January 2014. The study investigated the
effects of a moderate lifestyle intervention on GDM inci-
dence in women who were at high risk of GDM (18).
Participants were pregnant women, at or below 20 weeks
of gestation, and recruited due to a previous history of
GDM and/or a prepregnancy body mass index of
≥ 30 kg/m2. Exclusion criteria included: diabetes diagno-
sis before pregnancy, medications affecting glucose meta-
bolism, multiple pregnancies, physical disabilities, current
substance use and severe psychiatric disorders (18). All
participants consented to the 5-year follow-up study.
For the purposes of this study, stool samples were
obtained from RADIEL participants: 60 women diagnosed
with GDM during the RADIEL study, 68 non-GDM con-
trols, as well as their children (n = 109), in total n = 237.
As this was a pilot study, we analyzed samples from a simi-
lar number of women with GDM during the RADIEL preg-
nancy and compared them with women not diagnosed
with GDM during the RADIEL pregnancy. We included
the first 60 women and the first 68 controls from the 5-year
follow up for the present study. There were fewer children
than mothers included in the analyses due to some chil-
dren’s samples either not being present or there being inad-
equate amounts of sample material for sequencing.
Participants attended a clinical visit 5 years postpar-
tum. Measurements for glucose tolerance, blood pressure,
height, weight, body composition (InBody 3.0: InBody,
Seoul, South Korea) were assessed, for both mother and
child.
Stool samples were collected at home before the clinical
visit, using collection kits preloaded with stool DNA sta-
bilizer (PSP Spin Stool DNA Plus Kit: Stratec Molecular
GmbH, Berlin, Germany) (19). The tubes were then kept
in the subject’s home freezer until the clinical visit after
which they were stored at 80°C.
DNA extraction, polymerase chain reaction and
sequencing
PSP Spin Stool DNA Plus Kits (Stratec Molecular) were
used for total DNA extraction. Polymerase chain reaction
(PCR) amplification was performed using an ARKTIK
Thermal Cycler (Finnzymes Diagnostics- Thermo Fisher
Scientific, Finland). Further details in the Supplementary
material (Appendix S1).
Final PCR fragments were pooled in equal concentra-
tions and run on a MiSeq Sequencer (Illumina, San
Diego, CA, USA) using a v2 600 cycle kit paired-end
(325 bp + 285 bp). The complete data set consisted of
28 956 675 raw reads with an average of 121 667 raw
reads per sample (mothers: total 15 568 844, average
121 632; children: total 13 387 831, average 121 708).
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The DNA extraction, PCR and sequencing steps were
carried out at the DNA Sequencing and Genomics Labo-
ratory, University of Helsinki.
Sequence quality control, operational taxonomic
unit clustering and taxonomy assignment
CUTADAPT (20) and MOTHUR (21) were used for sequence
quality control, Operational Taxonomic Unit (OTU) clus-
tering and taxonomy assignment. Full details are given in
the Supplementary material (Appendix S1).
Diversity measurements and statistical data
analysis
OTU and taxonomy tables were imported into R (22) for
further analysis. The PHYLOSEQ package (23) was used for
handling sample metadata, taxonomy and sequence
counts.
Alpha diversity was compared using the inverse
Simpson and Shannon indices, calculated using PHY-
LOSEQ. The adonis function from the VEGAN R package
(24) was used to test for microbial community compo-
sitional differences between groups of samples (beta
diversity), using Bray–Curtis dissimilarity. Alpha diver-
sity comparisons were performed on nonrarefied data,
beta-diversity comparisons with data subsampled to the
number of reads in the sample with the least reads
(1359 for mothers, 1962 for children and 1359 for
mothers and children together). Kruskal–Wallis and
pairwise Wilcoxon rank sum tests were used to test for
statistically significant differences between groups. For
comparisons of beta diversity between sample pairs,
there were 99 related mother–child pairs, and to have
equally sized groups, 99 samples were randomly drawn
from each of the other groups (mother and unrelated
child, pairs of mothers, pairs of children); this sampling
was performed 100 times, and the average p-values of
these 100 comparisons were considered.
The DESEQ2 package (25) was used to identify taxa
that may show abundance differences between cases
and controls. To avoid including taxa that may be pre-
sent in only very few samples and that therefore may
produce trivially large effect sizes, OTUs that did not
have at least two sequences in at least 10 samples
were excluded from these comparisons. The Benjamini–
Hochberg multiple comparison correction was applied
and adjusted p-values were deemed significant when
p ≤ 0.05. The confounding variables included in the
statistical models consisted of age, parity (primiparous
or multiparous) and sequencing run (run 1 or run 2)
for the mothers and birthweight, sex and sequencing
run for the children.
Ethical approval
The present study was approved by the ethics committees




The clinical characteristics of the women were similar in
both groups, with the exception of plasma glucose levels
and body fat percentages (Table 1). Clinical characteristics
of the children showed no differences between the groups.
Diversity
No difference in alpha diversity was observed between the
GMD and non-GDM women; this was also the case when
comparing their offspring (all p-values > 0.5).
To test for community compositional differences
between the groups, beta diversity measures were per-
formed, with no significant beta diversity differences
being observed between the women (p = 0.7) or children
(p = 0.6).
A pairwise comparison of Bray–Curtis dissimilarity
between women and their own children, women and
unrelated children, all women, and all children, showed
that women and their own children have a microbial
community, which is much more similar (Figure 1). The
women and their own child group is significantly differ-
ent from all others (p < 0.001; median Bray–Curtis dis-
similarity 0.622 for women and their own children, 0.751
for women and unrelated children, 0.729 for mothers
compared with other mothers and 0.751 for children
compared with other children).
Overall microbiome composition
Looking at the bacterial genera present in the women, over
50% of the microbial community was made up by the four
most abundant taxa: Bacteroides (28.5%) (mean relative
abundance), Faecalibacterium (11.1%), Subdoligranulum
(8.2%) and Lachnospiracea incertae sedis (6.9%). 64 taxa
were not among the 15 most common genera and had a
combined relative abundance of 13.6%. In total, 79 genera
were identified. The microbiome profiles for GDM and
non-GDM groups were very similar, with only minor dif-
ferences observed between the two (Figure 2).
The top two genera in children were similar in abun-
dance to their mothers, Bacteroides at 32.5% and Faecal-
ibacterium at 10.9%. In contrast, the third most abundant
genus in mothers, Subdoligranulum, is only observed as
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the sixth most abundant taxon in the children at 4%. The
relative abundance of the top 15 genera and the overall
composition of the GDM and non-GDM groups in chil-
dren remained very similar, the largest difference being
observed in Prevotella where the abundance in GDM
(8.5%) was almost double that in non-GDM (4.8%) (Fig-
ure 2).
Differential abundance analysis
The DESEQ2 package was used to look for specific taxa
that may be differentially abundant between the women
and the children in each group of subjects.
OTU level. The comparisons did not reveal any OTUs
that differed significantly between the GDM and non-
GDM groups for either the mothers or the children.
Genus level. No significantly different taxa were identi-
fied between GDM and non-GDM mothers when com-
paring the abundances of genera.
Two genera, Anaerotruncus and Victivallis, were identi-
fied as significantly different between the two groups in
children (Figure 3a,b, Table 2). Both of these genera were
more abundant in the children of mothers with GDM.
Family level. Comparing the bacterial families present,
no significantly different abundances in taxa were identi-
fied between the two groups of women. Victivallaceae was
the only family identified as significantly different in chil-
dren between the two groups; its distribution was similar
to that of the genus Victivallis (Figure 3c, Table 2).
Comparisons of further clinical characteristics and
GDM subgroups. To identify any differences that may
exist in the microbiota of women based upon other clini-
cal characteristics, further DESEQ2 comparisons were run
on several variables available in the sample metadata and
a number of statistically significantly different taxa were
discovered (summarized in the Supplementary material,
Table S1 in Appendix S2). A full list of the taxonomy of
these specific taxa are included in Supplementary material
(Table S2 in Appendix S2).
Comparisons were also run on the individual con-
founding variables as well as on weight, body mass index,
height and cholesterol levels, to see whether any of these
variables may be associated with differences in microbiota
composition. No significant differences were observed
other than those reported in the Supplementary material
(Table S2).
Discussion
This study set out to compare the gut microbiota of
women who had been diagnosed with GDM, with that of
women who had undergone a normoglycemic pregnancy,
in addition to comparing microbiota of the offspring aris-
ing from the pregnancy 5 years postpartum. Although no
Table 1. Clinical characteristics of GDM and non-GDM control
groups.
GDM non-GDM p-value
Mothers (n = 60) (n = 68)
Months post delivery 59 (2.4) 59 (2.6) 0.99
Age (years) 39.2 (4.4) 37.7 (5.3) 0.14
Weight (kg) 84.4 (5.3) 92.5 (18.7) 0.07
Height (cm) 166.0 (0.02) 168.0 (0.1) 0.16
Body mass index
(kg/m2)
30.6 (1.8) 32.9 (6.3) 0.16
Waist (cm) 103.3 (4.3) 106.8 (16.5) 0.64
Hip (cm) 111.0 (3.8) 115.5 (12.6) 0.12
Waist/hip ratio 0.9 (0.02) 0.9 (0.06) 0.25
Fat-free mass (kg) 51.3 (1.9) 53.9 (6.8) 0.10
Percent body fat (%) 36.6 (2.5) 40.0 (8.9) <0.01
Systolic blood pressure
(mmHg)
125.2 (3.8) 124.6 (12.0) 0.62
Diastolic blood
pressure (mmHg)
79.6 (2.6) 79.0 (10.0) 0.45
Fasting P-glucose
(mmol/L)
5.7 (0.5) 4.9 (0.4) <0.01
2-h glucose (mmol/L) 6.6 (0.7) 5.6 (1.5) <0.01
Insulin (mU/l) 10.0 (1.9) 9.8 (5.2) 0.63
Fasting HDL (mmol/L) 1.5 (0.1) 1.5 (0.4) 0.87
Fasting triglyceride
(mmol/L)
0.9 (0.1) 0.9 (0.4) 0.25
Children (n = 57) (n = 52)
Age (months) at study 59.2 (3.1) 59.1 (2.8) 0.53
Birthweight (g) 3692 (466) 3634 (521) 0.55
Birth length (cm) 50.6 (2.2) 50.6 (2.4) 0.73
Weight (kg) 20.6 (3.3) 20.1 (2.8) 0.55
Height (cm) 111.5 (5.0) 112.3 (5.1) 0.38
Body mass index
(kg/m2)
16.5 (1.6) 15.9 (1.4) 0.06
Waist (cm) 55.0 (4.4) 54.3 (4.1) 0.44
Head circumference
(cm)
51.8 (1.5) 51.7 (1.4) 0.70
Systolic blood pressure
(mmHg)
100.6 (7.1) 102.3 (9.3) 0.72
Diastolic blood
pressure (mmHg)
62.2 (6.7) 63.2 (7.8) 0.71
Fasting P-glucose
(mmol/L)
5.2 (0.8) 5.0 (0.5) 0.31
Insulin (mU/l) 6.3 (5.5) 5.9 (6.2) 0.33
Fasting HDL (mmol/L) 1.6 (0.4) 1.5 (0.3) 0.82
Fasting triglyceride
(mmol/L)
0.8 (0.3) 0.9 (0.6) 0.99
GDM, gestational diabetes mellitus; HDL, high-density lipoprotein.
Values are presented as mean (SD). Normality of data was determined
using the Shapiro–Wilk test. p-values were then obtained by way of
t-tests or Mann–Whitney U-tests as required.
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Figure 1. Pairwise Bray–Curtis beta-diversity dissimilarity comparison between mothers and their own children, mothers and unrelated children,
all mothers, and all children. Pairwise Wilcoxon test significant p-values (based on averages of 100 samplings of 99 pairs from groups other than
mother and own child) are overlaid. Mothers and their own children have a microbial community that is much more similar compared with all
other comparisons carried out. [Color figure can be viewed at wileyonlinelibrary.com].
Figure 2. Mean relative abundance of the top 15 genera in gestational diabetes mellitus (GDM) and non-GDM groups. A total of 79 different
taxa were observed in mothers with 64 falling under the ‘other Taxa’ category. A total of 69 different taxa were observed in children with 59
falling under the ‘other Taxa’ category. [Color figure can be viewed at wileyonlinelibrary.com].
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community-wide differences were observed between the
post-GDM and non-GDM groups, three specific taxa
were identified as differentially abundant in the children.
Baseline characteristics between the groups were simi-
lar, except for glucose levels and body fat percentage in
the women. The difference in glucose levels between the
groups is not unexpected, as women who experience
GDM are at higher risk of type 2 diabetes in the future
(26).
A pairwise beta-diversity dissimilarity comparison
between women and their own children against all women,
all children, and women and nonrelated children reveals a
significantly greater similarity in the microbial communi-
ties in mothers and their own children, compared with the
rest. This result is expected, as children are more likely to
have a similar microbial community to their mothers, first
due to the maternal transfer of microbiota during birth and
subsequently via breastfeeding, but second due to the shar-
ing of the same environment as well as nutritional and diet-
ary habits as the child ages, which are key contributors to
gut microbiome colonization patterns (27). A child’s gut
microbiome is thought to undergo significant shifts until
approximately 2–3 years of age, after which it is susceptible
to fewer changes and represents a more adult-like micro-
biome (28).
No major differences in the top 15 genera abundances
can be seen between the GDM and non-GDM groups in
either the women or children. The most abundant taxa are
the same in all four groups: Bacteroides (phylum Bacteroide-
tes) and Faecalibacterium (phylum Firmicutes). Bacteroides
has been known as far back as the 1980s to be one of the
most abundant genera in the gut, making up approximately
25% of the microbial community (29). Faecalibacterium are
thought to make up anywhere between 5 and 20% of the gut
bacteria in healthy individuals (30). Although Tap et al.
report Faecalibacterium to be significant butyrate producers,
thought to increase insulin sensitivity (31), an increase in
Faecalibacterium species has been associated with obesity
and diabetes (32).
Fugmann et al. (33) have conducted the only study so
far aiming to investigate the gut microbiome in women
with a recent history of GDM (3–16 months postpartum)
including 42 post-GDM and 35 control subjects. Case













































































Figure 3. Relative abundances of the three different taxa identified as differentially abundant between the gestational diabetes mellitus (GDM)
and non-GDM groups in children. (a) Relative abundance of genus Anaerotruncus. (b) Relative abundance of genus Victiviallis. (c) Relative
abundance of family Victivallaceae. [Color figure can be viewed at wileyonlinelibrary.com].
















Genus Anaerotruncus 0.000 0.053 0.023–0.351 76.79 0.065 0.031–0.132 86.54
Genus Victivallis 0.005 0.000 0–0.088 33.93 0.000 0–0 15.38
Family Victivallaceae 0.004 0.000 0–0.088 33.93 0.000 0–0 15.38
GDM, gestational diabetes mellitus.
Significance defined as false discovery rate adjusted p < 0.05 in DESEQ2 comparisons. Medians and interquartile ranges are given for relative
abundances (%).
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several variables, which may be confounders for GDM,
such as adiposity, blood pressure and cholesterol concen-
trations, and whether these confounders were taken into
account in the analysis was not mentioned. In our study,
the subjects were much more uniform and similar, and
the sample size was also greater.
Results from the study by Fugmann et al. (33) suggest
that the Firmicutes phylum is reduced in subjects with
GDM compared with controls. In addition, a subset of par-
ticipants had a microbiome dominated by the Prevotellaceae
family compared with Bacteroidaceae in others. These
women were overrepresented in the GDM group, suggesting
a shift in the Bacteroidaceae/Prevotella ratio in GDM. As
with most human microbiome research to date, causality
cannot be inferred from forming correlations; establishing
whether the gut microbiome differences observed in this
study are in fact an outcome of disease state is of impor-
tance.
Statistical comparisons with DESEQ2 identified two
genera and one family as differentially abundant in the
children: genus Anaerotruncus, genus Victivallis and the
family Victivallaceae.
The Anaerotruncus genus was more abundant in the
children of women with a history of GDM compared
with those whose mothers did not have GDM. This genus
has been positively associated with both glucose intoler-
ance and gut permeability, suggesting a role in the patho-
genesis of diabetes (34). One study investigating the
effects of administering the probiotic yeast Saccharomyces
boulardii to diabetic mice showed a marked decrease in
Anaerotruncus abundance in S. boulardii-treated mice
(35). The probiotic-treated mice displayed lower body
weight and fat mass. Hyperglycemia in pregnancy confers
a significant increase in risk in the offspring of developing
diabetes or obesity in the future (2–4). This could be
explained in part by the gut microbiome differences
observed in the offspring of women with a history of
GDM compared with offspring of women with non-
GDM as evidenced here, although further investigation is
required to elucidate the full impact of such a difference.
The other differentially abundant taxa observed in chil-
dren, the genus Victivallis and the corresponding family,
Victivallaceae, were also more abundant in the GDM
group. These bacteria were only very recently described
(36) and established to separate the Victivallis genus from
the Lentisphaera. Victivallis is the sole genus in the family
Victivallaceae, and although described in 2003 (37), it has
not been reported in relation to the gut microbiome and
disease, or in fact even fully characterized. It must be
noted that the number of samples that represent a differ-
ence in abundance between the GDM and non-GDM
groups for these bacteria is limited: they are only present
in 34% of children in the GDM group and 15% in the
non-GDM group, bringing the significance of this result
into question.
The results obtained from additional clinical character-
istics and microbiota comparisons suggest that further
differences in the gut microbiota between the groups may
be seen, when using stricter criteria to define the GDM
subgroups. The heterogeneous nature of GDM could have
resulted in difficulty in observing putative associations
between the various features of GDM and the gut micro-
biome in women.
The present study was based on a convenience sample
of 128 women and their children. As this was a pilot
study, we aimed at similar numbers of women with
GDM and without GDM during the RADIEL-pregnancy
5 years earlier. The women belonging to the non-GDM
group in this study have risk factors for GDM. As a
result, they are not, perhaps in a traditional way, healthy
controls, but are high-risk persons. Therefore, further and
larger studies are needed to confirm these findings.
Conclusion
This exploratory study aimed to characterize the gut micro-
biome differences between women with a history of GDM
and nondiabetic, but high-risk, control women, as well as
their children, 5 years postpartum. Our findings suggest no
differences in the women, although differences between off-
spring to women with GDM and without GDM could be of
greater biological and clinical significance. The most inter-
esting finding is that of the Anaerotruncus genus in off-
spring, which warrants further studies to determine its role
in GDM and to investigate whether children with high
Anaerotruncus levels are at greater risk of developing dia-
betes or becoming obese when they mature.
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